USA – Aspen Neuroscience, a biotech developing the first autologous neuron replacement therapy for Parkinson’s disease, has closed a series B financing of $147.5 million to help get its autologous…
Read MoreAspen bags US$147 mln funding to advance personalized Parkinson’s cell therapy
